HOSPITAL UNIVERSITARIO RUBER
Departamento
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (3)
2024
2023
-
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
JAMA network open, Vol. 6, Núm. 11, pp. e2342107
2022
-
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
New England Journal of Medicine, Vol. 386, Núm. 6, pp. 556-567